ESC Premium Access

SGLT2 inhibitors in heart failure: adjusting other treatments and what to tell the patient.

Congress Session

About the speaker

Professor Avivit Cahn

Hadassah - Hebrew University Medical Center Jerusalem, Jerusalem (Israel)
2 presentations
0 follower

3 more presentations in this session

Who should be treated with an SGLT2 inhibitor?

Speaker: Professor J. McMurray (Glasgow, GB)

Thumbnail

SGLT2 inhibitors in heart failure: do I have to worry about the kidneys?

Speaker: Doctor K. Damman (Groningen, NL)

Thumbnail

Everything you need to know about SGLT2 inhibitors in heart failure – discussion.

Thumbnail

Access the full session

Everything you need to know about SGLT2 inhibitors in heart failure

Speakers: Professor A. Cahn, Professor J. McMurray, Doctor K. Damman
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

EHRA Premium Access

Conduction system pacing with AV node ablation versus catheter ablation for treatment of persistent atrial fibrillation in patients with heart failure with reduced ejection fraction

5 April 2022

EHRA Premium Access

Long QT syndrome.

5 April 2022

ACVC Premium Access

Clinical utility of the SCAI classification in cardiogenic shock patients of any etiology treated by a multidisciplinary team.

18 March 2022

This platform is supported by

logo Novo Nordisk